Literature DB >> 25270344

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?

Florian Gebauer1, Michael Tachezy, Yogesh K Vashist, Andreas H Marx, Emre Yekebas, Jakob R Izbicki, Maximilian Bockhorn.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to assess the overall survival (OS) after R0/R1 resections in patients with pancreatic ductal adenocarcinoma (PDAC) of the pancreatic head after implementation of a standardized histopathologic protocol (Leeds Pathology Protocol, LEEPP).
METHODS: One hundred and twenty-five patients underwent surgical resection because of PDAC of the pancreatic head. Patients were histopathologically examined according to a standardized protocol. Their oncologic outcome and clinicopathologic data were compared with those of a patient group before implementation of the LEEPP (n = 116).
RESULTS: The R1 rate increased significantly from 13 to 52 %. There was no significant difference in OS between R0 and R1 resections. The median OS in patients with a tumor clearance of less than 2 mm from the resection margin was 15.1 months (12.1-18.1 months) versus 22.2 months (7.8-36.7 months) (P = 0.046). Multivariate analysis revealed a margin clearance or 2 mm and more as an independent prognosticator for OS.
CONCLUSIONS: With applying the LEEPP, there was still no significant correlation between the R-status and OS in patients with PDAC. However, since a margin clearance of 2 mm or more is a predictive factor for OS, the R1 definition might have to be adapted in PDAC.

Entities:  

Mesh:

Year:  2015        PMID: 25270344     DOI: 10.1007/s00268-014-2808-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

Review 3.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

4.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

5.  Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula.

Authors:  Florian Gebauer; Katja Kloth; Michael Tachezy; Yogesh K Vashist; Guellue Cataldegirmen; Jakob R Izbicki; Maximilliam Bockhorn
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

Review 6.  Oncologic resection for malignant tumors of the liver.

Authors:  Shefali Agrawal; Jacques Belghiti
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

7.  Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.

Authors:  Jennifer L Gnerlich; Samuel R Luka; Anjali D Deshpande; Bernard J Dubray; Joshua S Weir; Danielle H Carpenter; Elizabeth M Brunt; Steven M Strasberg; William G Hawkins; David C Linehan
Journal:  Arch Surg       Date:  2012-08

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

9.  Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.

Authors:  Emre F Yekebas; Lars Wolfram; Guellue Cataldegirmen; Christian R Habermann; Dean Bogoevski; Alexandra M Koenig; Jussuf Kaifi; Paulus G Schurr; Michael Bubenheim; Claus Nolte-Ernsting; Gerhard Adam; Jakob R Izbicki
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more
  18 in total

1.  Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer.

Authors:  Masayuki Tanaka; Yosuke Inoue; Kiyoshi Matsueda; Makiko Hiratsuka; Mariko Muto; Shoji Kawakatsu; Yoshihiro Ono; Yoshihiro Mise; Takeaki Ishizawa; Hiromichi Ito; Yu Takahashi; Yutaka Takazawa; Akio Saiura
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

2.  Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.

Authors:  Asmita Chopra; Mazen Zenati; Melissa E Hogg; Herbert J Zeh; David L Bartlett; Nathan Bahary; Amer H Zureikat; Joal D Beane
Journal:  Ann Surg Oncol       Date:  2021-05-23       Impact factor: 5.344

3.  Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center.

Authors:  William B Lyman; Michael Passeri; Amit Sastry; Allyson Cochran; David A Iannitti; Dionisios Vrochides; Erin H Baker; John B Martinie
Journal:  Surg Endosc       Date:  2018-11-12       Impact factor: 4.584

4.  Pancreatic resections in elderly patients with high American Society of Anesthesiologists' risk score: a view from a tertiary care center.

Authors:  Gregorio Di Franco; Matteo Palmeri; Simone Guadagni; Niccolò Furbetta; Desirée Gianardi; Jessica Bronzoni; Alessandro Palma; Matteo Bianchini; Serena Musetti; Luca Bastiani; Giovanni Caprili; Giandomenico Biancofiore; Franco Mosca; Giulio Di Candio; Luca Morelli
Journal:  Aging Clin Exp Res       Date:  2019-07-25       Impact factor: 3.636

5.  Landmark Series: Importance of Pancreatic Resection Margins.

Authors:  Mihir M Shah; Jashodeep Datta; Nipun B Merchant; David A Kooby
Journal:  Ann Surg Oncol       Date:  2022-01-05       Impact factor: 5.344

6.  Long-term survival in patients with pancreatic ductal adenocarcinoma.

Authors:  Alexander P Stark; Greg D Sacks; Matthew M Rochefort; Timothy R Donahue; Howard A Reber; James S Tomlinson; David W Dawson; Guido Eibl; O Joe Hines
Journal:  Surgery       Date:  2016-02-02       Impact factor: 3.982

7.  Comparison of Uncinate Process Cancer and Non-Uncinate Process Pancreatic Head Cancer.

Authors:  Chang Liu; Xiaodong Tian; Xuehai Xie; Hongqiao Gao; Yan Zhuang; Yinmo Yang
Journal:  J Cancer       Date:  2016-06-21       Impact factor: 4.207

8.  Pathological Margin Clearance and Survival After Pancreaticoduodenectomy in a US and European Pancreatic Center.

Authors:  Stijn van Roessel; Gyulnara G Kasumova; Omidreza Tabatabaie; Sing Chau Ng; L Bengt van Rijssen; Joanne Verheij; Robert M Najarian; Thomas M van Gulik; Marc G Besselink; Olivier R Busch; Jennifer F Tseng
Journal:  Ann Surg Oncol       Date:  2018-04-12       Impact factor: 5.344

9.  Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.

Authors:  Tsengelmaa Jamiyan; Takayuki Shiraki; Yoshihiro Kurata; Masanori Ichinose; Keiichi Kubota; Yasuo Imai
Journal:  World J Surg Oncol       Date:  2020-06-22       Impact factor: 2.754

Review 10.  Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Kyung Su Kim; Jeanny Kwon; Kyubo Kim; Eui Kyu Chie
Journal:  Cancer Res Treat       Date:  2016-08-26       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.